Literature DB >> 7371464

Observations on 261 consecutive patients with inflammatory bowel disease seen in the Southwest United States.

W W Robison, P S Bentlif, J R Kelsey.   

Abstract

Two hundred and sixty-one consecutive patients with inflammatory bowel disease (IBD) were seen at a private medical and surgical clinic affiliated with Baylor College of Medicine in Houston, Texas, between November 1, 1975, and March 1, 1979. We collected social and demographic data concerning date and place of birth, sex, race, religion, marital status, date and place of disease onset and occupation, in order to determine whether the presentation of IBD in the southwest United States differs from that in other regions. Clinical data concerning presenting symptoms, area of bowel involvement, and number of hospitalizations were tabulated in order to evaluate the mortality and morbidity of disease. Where applicable statistical analysis of the data was accomplished by computer to determine the significance of the findings. Inflammatory bowel disease was noted to be a disease predominantly of whites, with relative sparing of blacks and Latin Americans. Thirteen cases of IBD occurred in a neighboring white, non-Jewish community of Orange, Texas, during the period of study. In the 261 cases morbidity was severe, but the mortality rate was low. There was one death from suicide. No surgical mortalities were noted in 106 patients who underwent one to ten surgical procedures.

Entities:  

Mesh:

Year:  1980        PMID: 7371464     DOI: 10.1007/bf01308139

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Crohn's disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmö, Sweden.

Authors:  F Brahme; C Lindström; A Wenckert
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

2.  An association between ulcerative colitis, regional enteritis, and ankylosing spondylitis.

Authors:  E D ACHESON
Journal:  Q J Med       Date:  1960-10

3.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

4.  The demographic and social characteristics of patients with Crohn's disease in the Nottingham area.

Authors:  A Keighley; D S Miller; A O Hughes; M J Langman
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

5.  Crohn's disease in the Jewish population of Tel-Aviv-Yafo. Epidemiologic and clinical aspects.

Authors:  P Rozen; J Zonis; P Yekutiel; T Gilat
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

6.  Ulcerative colitis in the Jewish population of Tel-Aviv Jafo. I. Epidemiology.

Authors:  T Gilat; J Ribak; Y Benaroya; Z Zemishlany; I Weissman
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

7.  An epidemiological study of Crohn's disease in Northeast Scotland.

Authors:  J Kyle
Journal:  Gastroenterology       Date:  1971-12       Impact factor: 22.682

8.  The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients.

Authors:  B H Rogers; L M Clark; J B Kirsner
Journal:  J Chronic Dis       Date:  1971-12

9.  An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore. II. Social and demographic factors.

Authors:  M Monk; A I Mendeloff; C I Siegel; A Lilienfeld
Journal:  Gastroenterology       Date:  1969-05       Impact factor: 22.682

10.  An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.

Authors:  J G Evans; E D Acheson
Journal:  Gut       Date:  1965-08       Impact factor: 23.059

View more
  1 in total

1.  Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.

Authors:  N Shiobara; Y Suzuki; H Aoki; A Gotoh; Y Fujii; Y Hamada; S Suzuki; N Fukui; I Kurane; T Itoh; R Suzuki
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.